The hybridoma method is a mainstay for monoclonal antibody (mAb) production (including the hapten-associated small molecule antibody), during the whole workflow, the accurate and specific screening of positive hybridomas usually determines the success. Commonly, positive antibody-secreting subclones are screened and selected by a solid-phase enzyme-linked immunosorbent assay (ELISA).